1. Yu D, Liu Z, Su C, Han Y, Duan X, Zhang R, Liu X, Yang Y, Xu S*..Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier.Thorac Cancer.2020.11(1).95-102.SCI |
2. Zhang R, Ma L, Li W, Zhou S, Xu S.*.Diagnostic value of multiple tumor-associated autoantibodies in lung cance.Onco Targets Ther. .2019.9(12).457-469.SCI |
3. Yu Pang,1 Jun An,1 Wei Shu,1 Fengmin Huo, Naihui Chu, Mengqiu Gao, Shibing Qin, Hairong Huang, Xiaoyou Chen, Shaofa Xu*.Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008–2017.Emerg Infect Dis..2019.25(3). 457–464..SCI |
4. Yuhong Liu, Yu Pang, Jian Du, Wei Shu, Yan Ma, Jingtao Gao, Lijie Zhang, Shaofa Xu*, Liang Li*.An Overview of Tuberculosis-Designated Hospitals in China, 2009-2015: A Longitudinal Analysis of National Survey Data.Biomed Res Int..2019.20(1).917-925.SCI |
5. Duan X, Zhu Y, Cui Y, Yang Z, Zhou S, Han Y, Yu D, Xiao N, Cao X, Li Y, Liu S, Wang Z, Zhang W, Feng L, Zhang K, Shou J, Liu Z, Xu S.*.Circulating tumor cells in the pulmonary vein increase significantly after lobectomy: A prospective observational study.Thorac Cancer..2019.10(2).163-169..SCI |
6. Ren Z, Zhou S, Liu Z, Xu S..Randomized controlled trials of induction treatment and surgery versus combined chemotherapy and radiotherapy in stages IIIA-N2 NSCLC: a systematic review and meta-analysis.J Thorac Dis.2016. 7(8).1414-22.SCI |
7. Yang Z, Wang Z, Duan Y, Xu S..Clinicopathological characteristics and prognosis of resected cases of carcinoid tumors of the lung..Thorac Cancer.2016.7(6).633-638.SCI |
8. Yanlin Zhao, Ph.D#, Shaofa Xu, M.D.# Lixia Wang, M.S.#Daniel P. Chin, M.D., Shengfen Wang, Ph.D., Guanglu Jiang, B.S., Hui Xia, M.S., Yang Zhou, M.S., Qiang Li, M.S., Xichao Ou, M.S., Yu Pang, Ph.D., Yuanyuan Song, B.S., Bing Zhao, B.S., Hongtao Zhang, Ph.D., Guangxue He, B.S., Jing Guo, Ph.D.,.National Survey of Drug-Resistant Tuberculosis in China. N Engl J Med.2012.366.366: 2161-70.SCI |
9. Yue W, Zhao X, Zhang L, Liu Z, Ma L, Jia W, Qian Z, Zhang C, Wang Y, Yang X, Xu S*.Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation. SCIENCE CHINA Life Sciences(Science SCIENCE CHINA Life Sciences).2010.53(4).511-516.SCI |
10. 李元,岳文涛,王玥, 张丽娜,顾勐, 许绍发*.应用多肽芯片研究非小细胞肺癌患者血清中的EGFR自身抗体 . 中国肺癌杂志.2010.13(7).727.核心期刊 |
11. L. Yang , G.L. Shi , C.X. Song . S.F. Xu*.Analysis of HLA-A, HLA-B and HLA-DRB1 alleles in Chinese patients with lung cancer.Genetics and Molecular Research.2010.9 (2).750-755.SCI |
12. L. Yang , G.L. Shi , C.X. Song . S.F. Xu*.relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China.Genetics and Molecular Research.2010. 9 (2).765-771 .SCI |
13. 宋小运; 许绍发*; 刘志东; 刘树库; 周世杰; 韩毅.恶性胸膜间皮瘤术后预后因素分析.中华肿瘤防治杂志,.2010.17(18).1467-1469.核心期刊 |
14. 杨磊 ; 时广利 ; 宋长兴; 许绍发(*).中国北方地区汉族人群MCP-1基因多态性与肺癌相关性研究.中华微生物学和免疫学杂志.2010.30(4).336.核心期刊 |
15. 刘志东, 许绍发(*),肖宁,宋长兴, 张海青,李福根.IL-8和MMP-9在非小细胞肺癌患者组织及血清中表达水平的研究 .中国肺癌杂志.2010.13(8).795-802.核心期刊 |
16. 唐恺; 岳文涛; 王玥; 张丽娜; 许绍发*.一种检测非小细胞肺癌患者血清中p53自身抗体的新方法 .中国肺癌杂志.2009.12(9).969-974.核心期刊 |
17. Ke-Neng Chen, MD, PhD,1* Shao-Fa Xu, MD, PhD,4* Zhen-Dong Gu, MD,1.Surgical Treatment of Complex Malignant Anterior Mediastinal Tumors Invading the Superior Vena Cava.World J Surg.2006.30.162–170.SCI |